SLGL — SOL-GEL TECHNOLOGIES Share News
0.000.00%
- $227.38m
- $179.45m
- $19.39m
Brief: Sol-Gel Technologies Reports First Quarter 2022 Financial Results And Provides Corporate Update
Sol Gel Technologies Ltd expected to post a loss of 29 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Broadcom Inc, Intuit Inc, GoDaddy Inc
U.S. STOCKS ON THE MOVE-Kellogg Co, Tesla Inc, Cango Inc
Sol-Gel rises on FDA approval of skin disease cream
Brief: Sol-Gel Technologies And Galderma Announce FDA Approval Of Epsolay
Brief: Sol-Gel Technologies Reports Commercial Availability Of Twyneo
Sol Gel Technologies Ltd reports results for the quarter ended in December - Earnings Summary
Brief: Sol-Gel Technologies Reports Full Year 2021 Financial Results And Corporate Developments
Sol Gel Technologies Ltd expected to post earnings of 41 cents a share - Earnings Preview
Brief: Sol-Gel Technologies Announces Positive Update Related To FDA Review Status Of Epsolay
Sol Gel Technologies Ltd reports results for the quarter ended in September - Earnings Summary
Brief: Sol-Gel Technologies Reports Third Quarter 2021 Financial Results
Sol Gel Technologies Ltd expected to post a loss of 7 cents a share - Earnings Preview
Sol Gel Technologies Ltd reports results for the quarter ended in June - Earnings Summary
Brief: Sol-Gel Technologies Posts Qtrly Loss Per Share 35 Cents
Sol Gel Technologies Ltd expected to post a loss of 21 cents a share - Earnings Preview
Brief: Sol-Gel Technologies Announces FDA Approval Of Twyneo®
NASDAQ TRADE HALT HALT NEWS PENDING AT 09:41 AM